Regulatory Polymorphisms in -Tubulin IIa Are Associated With Paclitaxel-Induced Peripheral Neuropathy

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-12-1221
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Genetic Polymorphisms of SCN9A Are Associated With Oxaliplatin-Induced Neuropathy

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Estrogen Deficiency Aggravates Paclitaxel-Induced Peripheral Neuropathy: Involvement of HMGB1

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Polymorphisms in Cytochromes P450 2C8 and 3A5 Are Associated With Paclitaxel Neurotoxicity

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2010English

Acetyl-L-Carnitine Prevents and Reduces Paclitaxel-Induced Painful Peripheral Neuropathy

Neuroscience Letters
Neuroscience
2006English

Peripheral Neuropathy Associated With Simvastatin.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1995English

RWDD3andTECTAvariants Not Linked to Paclitaxel Induced Peripheral Neuropathy in North American Trial Alliance N08C1

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2014English

Peripheral Neuropathy Associated With Dialysis Amyloidosis.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1994English

Evoked and Ongoing Pain-Like Behaviours in a Rat Model of Paclitaxel-Induced Peripheral Neuropathy

Pain Research and Management
NeurologyAnesthesiologyPain Medicine
2018English

Chemotherapy-Induced Peripheral Neuropathy

JAMA Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy